Jci_page_head_homepage_01 Jci_page_head_homepage_02
Nelly A. Kuklin, Lusijah Rott, Jama Darling, James J. Campbell, Manuel Franco, Ningguo Feng, Werner Müller, Norbert Wagner, John Altman, Eugene C. Butcher, Harry B. Greenberg
Published in Volume 106, Issue 12
J Clin Invest. 2000; 106(12):1541–1552 doi:10.1172/JCI10927
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 7

Percentage of CD8+ TCRαβ+ cells in IELs, MLNs, and spleens of mice transferred with β7–/– or wt CD8+ T cells at indicated times after transfer. (a) Percentage of CD8+ TCRαβ+ FITC-labeled cells. Splenocytes from nonimmune β7–/– or wt mice were labeled in vitro with FITC and 107 cells were injected intravenously into C57BL/6 recipient mice. Three hours following injection of the labeled cells, recipient mice were sacrificed and percentages of CD8+ T cells in the indicated tissues were determined by FACS. (b, c, and d) Chronically infected Rag-2 mice were adoptively transferred with 5 × 105 CD8+ T cells from RV immune β7–/– or wt mice. Seven (b), 14 (c), and 30 (d) days after transfer, recipient mice were sacrificed and cells from IEL, MLNs, and spleen were analyzed by FACS. Each group consisted of six animals. Differences in percentages of CD8+ T cells between groups (each comprising six animals) were not statistically significant using standard t test (P > 0.05). Note that the scales in a and b are different because fewer CD8+ T cells were detected at 3 hours than at 7 days following adoptive transfer.